+1 (207) 809‑0335 
Medical research is changing, data privacy laws have not
Congressional inaction regarding health privacy laws robs Americans of ownership over their health data, argues Senator Bill Cassidy, ranking member of the Senate HELP...
Hospitals’ COVID reporting burden to lighten as pandemic-era policies expire
On Wednesday, hospitals will no longer be required to report COVID-19 admissions, capacity or occupancy data to the federal government....
California, Oregon eye universal health coverage
The states have proposed creating insurance systems similar to Medicare for All. But the plans need approval from the federal...
The aftermath of Change: Two experts on how healthcare organizations can prevent the next cyberattack
Providers should form a cyber strategy involving incident response plans, testing, multifactor authentication and automating tasks, according to managing directors at NetSPI....
Providers, drugmakers at odds over new 340B dispute resolution process
HRSA finalized a rule on Thursday meant to make arbitration more accessible and efficient. Article By: Rebecca Pifer Blog Source...
More than three-fourths of doctors are employed by corporations, report finds
Rampant consolidation continues to threaten the existence of independent physicians, according to a new report from Avalere and the Physicians...
Change asks to consolidate dozens of cyberattack class-action lawsuits
Twenty-four cases have racked up so far against the UnitedHealth subsidiary following a cyberattack against the technology firm in late...
School-based Medicaid billing concerns delay proposed rule
Some worry children’s school-based services can adversely affect outside services, but school administrators said there have been no examples of...
Healthcare companies expand perks to recruit talent: report
The increase stands in contrast to other industries, which have cut back on extra offerings. Article By: Susanna Vogel Blog Source...
As laboratory-developed test rule looms, experts warn patients may lose access to critical diagnostics
In testimony to Congress Thursday, industry and patient group leaders described the trade-offs expected from increased FDA oversight of laboratory-developed...
